Substantia innominata

From WikiMD's WELLNESSPEDIA

Substantia Innominata is a region of the brain that is part of the Basal forebrain. It is a part of the telencephalon and is located in the anterior part of the brain. The Substantia Innominata is composed of both gray matter and white matter.

Anatomy[edit]

The Substantia Innominata is a part of the Basal forebrain and is located in the anterior part of the brain. It is composed of both gray matter and white matter. The gray matter is made up of neurons, while the white matter is made up of axons. The Substantia Innominata is located below the anterior commissure and above the optic tract.

Function[edit]

The Substantia Innominata plays a crucial role in the cholinergic system, which is involved in memory and learning. It is also involved in the regulation of sleep and wakefulness. The Substantia Innominata is also associated with the limbic system, which is involved in emotion, behavior, motivation, long-term memory, and olfaction.

Clinical significance[edit]

Damage to the Substantia Innominata can lead to a variety of neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. In Alzheimer's disease, there is a significant loss of neurons in the Substantia Innominata, which leads to a decrease in the production of acetylcholine, a neurotransmitter that is crucial for memory and learning.

See also[edit]

References[edit]


This article is a stub related to anatomy. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.